Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.

Newron and EA Pharma secure landmark licensing deal to advance schizophrenia treatment

Pallavi Madhiraju- December 15, 2024 0

In a move set to transform treatment options for patients with schizophrenia, Newron Pharmaceuticals S.p.A. ("Newron") has entered into a high-value licensing agreement with EA ... Read More

Nintx secures $10m to drive breakthrough therapies harnessing Brazilian biodiversity

Pallavi Madhiraju- December 15, 2024 0

Nintx (Next Innovative Therapeutics), a rising star in Brazil’s biotechnology sector, has successfully raised $10 million in a Series A funding round. This significant milestone, ... Read More

BrightPath Bio, Cellistic join forces to advance iPSC-derived CAR-NKT cell therapy for multiple myeloma

Pallavi Madhiraju- December 15, 2024 0

BrightPath Bio and Cellistic have entered into a collaboration aimed at advancing iPSC-derived CAR-NKT cell therapy. This partnership focuses on process development and clinical-scale manufacturing ... Read More

Galderma’s Nemluvio gains FDA nod for moderate-to-severe atopic dermatitis

Pallavi Madhiraju- December 15, 2024 0

Galderma has achieved a significant milestone with the U.S. Food and Drug Administration’s (FDA) approval of Nemluvio (nemolizumab) for treating moderate-to-severe atopic dermatitis in patients ... Read More

Swiss biotech company Noema Pharma secures CHF130m to advance CNS therapies

Pallavi Madhiraju- December 15, 2024 0

Basel, Switzerland-based Noema Pharma, a clinical-stage biotech company, has announced the successful close of its Series B financing round extension, securing CHF 130 million (approximately ... Read More

Novo Nordisk set to finalize $11bn acquisition of Catalent manufacturing sites

Pallavi Madhiraju- December 14, 2024 0

Novo Nordisk is set to finalise its acquisition of three Catalent manufacturing sites, marking a pivotal step in its strategy to bolster global manufacturing capabilities ... Read More

AbbVie to expand immunology pipeline with Nimble Therapeutics acquisition

Pallavi Madhiraju- December 14, 2024 0

In a significant move to solidify its presence in immunology, AbbVie has announced the acquisition of Nimble Therapeutics, a company at the forefront of peptide-based ... Read More

Inovio Pharmaceuticals faces tumultuous stock reaction to $30m offering

Pallavi Madhiraju- December 14, 2024 0

Inovio Pharmaceuticals, a biotechnology company specialising in DNA medicines, witnessed a sharp decline in its stock value following the announcement of a $30 million public ... Read More

Lupin acquires diabetes trademarks from Boehringer Ingelheim to bolster treatment portfolio

Pallavi Madhiraju- December 14, 2024 0

Lupin Limited, a global pharmaceutical leader based in Mumbai, has announced the acquisition of three anti-diabetes trademarks—GIBTULIO, GIBTULIO MET, and AJADUO—from Boehringer Ingelheim International GmbH. ... Read More

Rakovina Therapeutics’ private placement fuels DNA-damage response therapies

Pallavi Madhiraju- December 14, 2024 0

Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company pioneering innovative cancer therapies through advancements in DNA-damage response technologies, has successfully closed an oversubscribed private placement ... Read More